2016\u5e747\u670828\u65e5<\/p>\n
\u30b7\u30df\u30c3\u30af\u682a\u5f0f\u4f1a\u793e
\n³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
\u30b7\u30df\u30c3\u30af\u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e\uff1a \u6771\u4eac\u90fd\u6e2f\u533a\u3001\u4ee3\u8868\u53d6\u7de0\u5f79\uff1a \u597d\u672c\u3000\u4e00\u90ce\u3001\u4ee5\u4e0b CMIC\uff09\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306b\u304a\u3044\u3066\u6700\u5148\u7aef\u306e\u30af\u30e9\u30a6\u30c9\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3092\u6d3b\u7528\u3057\u305f³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e\uff1a \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u4ee3\u8868\u53d6\u7de0\u5f79: \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ\uff09\u306e\u88fd\u54c1\u300eVault eTMF<\/a><\/span>\u300f\u3092\u6cbb\u9a13\u95a2\u9023\u6587\u66f8(TMF)\u7ba1\u7406\u306e\u63a8\u5968\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068\u3057\u3066\u63a1\u7528\u3057\u3001³Ô¹Ï±¬ÁÏ\u3068CRO\u696d\u52d9\u306b\u304a\u3051\u308b\u30d1\u30fc\u30c8\u30ca\u30fc\u63d0\u643a\u3092\u3044\u305f\u3057\u307e\u3057\u305f<\/p>\n \u80cc\u666f\uff1a CMIC\u3068³Ô¹Ï±¬ÁÏ\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u63d0\u643a\uff1a \u3010\u30b7\u30df\u30c3\u30af\u30b0\u30eb\u30fc\u30d7\u306b\u3064\u3044\u3066\u3011<\/strong> <\/p>\n \u3010<\/strong>³Ô¹Ï±¬ÁÏ Systems<\/strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> <\/p>\n \u3010Forward-looking Statements\u3011<\/strong> 2016\u5e747\u670828\u65e5 \u30b7\u30df\u30c3\u30af\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e \u30b7\u30df\u30c3\u30af\u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e\uff1a \u6771\u4eac\u90fd\u6e2f\u533a\u3001\u4ee3\u8868\u53d6\u7de0\u5f79\uff1a \u597d\u672c\u3000\u4e00\u90ce\u3001\u4ee5\u4e0b CMIC\uff09\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306b\u304a\u3044\u3066\u6700\u5148\u7aef\u306e\u30af\u30e9\u30a6\u30c9\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3092\u6d3b\u7528\u3057…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-39011","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study","blog-product-veeva-rd","blog-product-veeva-vault"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/39011"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=39011"}],"version-history":[{"count":7,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/39011\/revisions"}],"predecessor-version":[{"id":39023,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/39011\/revisions\/39023"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=39011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=39011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=39011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\u8fd1\u5e74\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3067\u306f\u3001ICH E6(R2) – Integrated Addendum: Guideline for Good Clinical Practice(\u533b\u85ac\u54c1\u306e\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u306b\u95a2\u3059\u308b\u57fa\u6e96\u30ac\u30a4\u30c9\u30e9\u30f3\u306e\u88dc\u907a)\u3078\u306e\u30d1\u30d6\u30ea\u30c3\u30af\u30b3\u30e1\u30f3\u30c8\u306e\u52df\u96c6\u304c\u7de0\u3081\u5207\u3089\u308c\u308b\u306a\u3069\u3001\u6cbb\u9a13\u696d\u52d9\u306b\u304a\u3051\u308b\u300c\u54c1\u8cea\u30de\u30e1\u30f3\u30b8\u30e1\u30f3\u30c8\u300d\u3092\u91cd\u8981\u8996\u3057\u305f\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u3084\u30c7\u30fc\u30bf\u306b\u5bfe\u3059\u308b\u30ea\u30b9\u30af\u306e\u8a55\u4fa1\u3001\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u304a\u3088\u3073\u30ea\u30b9\u30af\u5831\u544a\u306e\u7fa9\u52d9\u5316\u306b\u9032\u307f\u3064\u3064\u3042\u308a\u307e\u3059\u3002
\n\u307e\u305f\u3001\u65e5\u672c\u306b\u304a\u3044\u3066\u3082\u88fd\u85ac\u4f01\u696d43\u793e\u306b\u3088\u308b\u96fb\u78c1\u5316\u5b9f\u88c5\u691c\u8a0e\u4f1a\u304c\u958b\u50ac\u3055\u308c\u308b\u306a\u3069\u3001\u6cbb\u9a13\u95a2\u9023\u6587\u66f8\u306e\u96fb\u5b50\u4ea4\u63db(eTMF)\u306e\u305f\u3081\u306e\u5177\u4f53\u7684\u306a\u53d6\u308a\u7d44\u307f\u304c\u306a\u3055\u308c\u3001\u96fb\u5b50\u5316\u306b\u5411\u3051\u305f\u52d5\u304d\u304c\u6d3b\u767a\u5316\u3057\u3066\u304d\u3066\u304a\u308a\u307e\u3059\u3002
\n\u3053\u308c\u3089\u306e\u72b6\u6cc1\u3092\u3075\u307e\u3048\u3001\u88fd\u85ac\u4f01\u696d\u306f\u3001\u6cbb\u9a13\u696d\u52d9\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u3067\u3042\u308bCRO\u306b\u5bfe\u3057\u3001\u5358\u306a\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u306e\u6cbb\u9a13\u95a2\u9023\u6587\u66f8\u306e\u96fb\u5b50\u4fdd\u7ba1\u3084\u4fdd\u7ba1\u7ba1\u7406\u306e\u307f\u306a\u3089\u305a\u3001\u6cbb\u9a13\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u3068\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u9069\u6b63\u5316\u3001\u6587\u66f8\u306e\u54c1\u8cea\u30ea\u30b9\u30af\u306a\u3069\u3092\u6307\u6a19\u3068\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u652f\u63f4\u3092\u884c\u3046\u9769\u65b0\u7684\u306a\u6cbb\u9a13\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u6c42\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n
\nCMIC\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u30ec\u30d9\u30eb\u3067\u306e\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u4f53\u5236\u3092\u3044\u3061\u65e9\u304f\u6574\u5099\u3059\u308b\u305f\u3081\u30012014\u5e74\u306b\u300e³Ô¹Ï±¬ÁÏ Vault QualityDocs<\/a><\/span>\u300f\u3092\u5c0e\u5165\u3057\u3001\u3055\u3089\u306a\u308b\u6cbb\u9a13\u30d7\u30ed\u30bb\u30b9\u306e\u52b9\u7387\u5316\u3001\u8fc5\u901f\u5316\u306e\u305f\u3081\u3001\u300e³Ô¹Ï±¬ÁÏ Vault eTMF\u300f\u3092CRO\u696d\u52d9\u306b\u304a\u3051\u308b\u6cbb\u9a13\u95a2\u9023\u6587\u66f8\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068\u3057\u3066\u63a1\u7528\u3057\u3001³Ô¹Ï±¬ÁÏ\u3068\u30d1\u30fc\u30c8\u30ca\u30fc\u63d0\u643a\u3059\u308b\u3053\u3068\u306b\u3044\u305f\u3057\u307e\u3057\u305f\u30022017\u5e741\u6708\u3088\u308a³Ô¹Ï±¬ÁÏ Vault eTMF \u3092\u7528\u3044\u305f\u6587\u66f8\u7ba1\u7406\u3092\u63d0\u4f9b\u958b\u59cb\u4e88\u5b9a\u3067\u3059\u3002
\n\u3053\u306e\u63d0\u643a\u306b\u3088\u3063\u3066\u3001CMIC\u306fTMF\u6587\u66f8\u306b\u304a\u3051\u308b\u9ad8\u3044\u54c1\u8cea\u696d\u52d9\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u4fdd\u3061\u3001\u591a\u304f\u306e\u88fd\u85ac\u4f01\u696d\u306b\u5bfe\u3057\u6cbb\u9a13\u30d3\u30b8\u30cd\u30b9\u306e\u52b9\u7387\u5316\u3068\u4ed8\u52a0\u4fa1\u5024\u3092\u63d0\u4f9b\u3057\u7d9a\u3051\u307e\u3059\u3002<\/p>\n
\n\u30b7\u30df\u30c3\u30af\u30b0\u30eb\u30fc\u30d7\u306f\u30011992\u5e74\u306b\u65e5\u672c\u3067\u521d\u3081\u3066CRO\uff08\u533b\u85ac\u54c1\u958b\u767a\u652f\u63f4\uff09\u4e8b\u696d\u3092\u958b\u59cb\u3057\u3001\u4eca\u3067\u306f\u958b\u767a\u304b\u3089\u88fd\u9020\u3001\u55b6\u696d\u30fb\u30de\u30fc\u30b1\u30c6\u30a3\u30f3\u30b0\u307e\u3067\u306e\u533b\u85ac\u54c1\u306b\u95a2\u3059\u308b\u7dcf\u5408\u7684\u306a\u652f\u63f4\u696d\u52d9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u30d8\u30eb\u30b9\u30b1\u30a2\u4e8b\u696d\u3001\u8a3a\u65ad\u85ac\u3084\u30aa\u30fc\u30d5\u30a1\u30f3\u30c9\u30e9\u30c3\u30b0\u306e\u81ea\u793e\u3067\u306e\u958b\u767a\u8ca9\u58f2\u306a\u3069\u3082\u884c\u3044\u3001\u591a\u69d8\u5316\u3059\u308b\u30cb\u30fc\u30ba\u306b\u5bfe\u5fdc\u3057\u3066\u3044\u307e\u3059\u3002\u5e45\u5e83\u3044\u7d4c\u9a13\u3068CRO\u306e\u30d1\u30a4\u30aa\u30cb\u30a2\u3068\u3057\u3066\u84c4\u7a4d\u3057\u305f\u30ce\u30a6\u30cf\u30a6\u3092\u30d9\u30fc\u30b9\u306b\u3001\u72ec\u81ea\u306e\u30d3\u30b8\u30cd\u30b9\u30e2\u30c7\u30ebPVC\uff08Pharmaceutical Value Creator\uff09\u306e\u69cb\u7bc9\u3092\u9032\u3081\u3001\u533b\u85ac\u54c1\u4e8b\u696d\u306b\u304a\u3051\u308b\u4ed8\u52a0\u4fa1\u5024\u306e\u5275\u751f\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u30db\u30fc\u30e0\u30da\u30fc\u30b8\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002
\n\u30b7\u30df\u30c3\u30af\u30db\u30fc\u30eb\u30c7\u30a3\u30f3\u30b0\u30b9\u682a\u5f0f\u4f1a\u793e\uff1ahttp:\/\/www.cmic-holdings.co.jp<\/strong>
\n\u30b7\u30df\u30c3\u30af\u682a\u5f0f\u4f1a\u793e\uff1ahttp:\/\/www.cmic.co.jp<\/strong><\/p>\n
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067400\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/span>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in the company\u2019s filing on Form 10-Q for the period ended July 31, 2015. This is available on the company\u2019s website at http:\/\/www.veeva.com<\/span> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/span>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"